Stock Price
616.80
Daily Change
3.00 0.49%
Monthly
-13.15%
Yearly
10.10%
Q1 Forecast
598.33

argenx SE reported $7.18B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
AstraZeneca USD 114.07B 382M Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
UCB EUR 17.35B 1.72B Dec/2024